Melatonin and DNA Damage Study

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

November 1, 2023

Study Completion Date

November 1, 2023

Conditions
Sleep QualityDNA Damage Repair DeficiencyOxidative Stress
Interventions
DIETARY_SUPPLEMENT

Melatonin

Participants will be randomized into two groups (Group A and Group B). Group A will initially be treated with 3 mg melatonin supplements over a 4-week period while Group B will initially receive placebo supplements over a 4-week period. After a 4-week washout period, Group A will receive placebo supplements while Group B will receive 3 mg melatonin supplements.

OTHER

Placebo

Placebo

Trial Locations (1)

V5Z 1L3

BC Cancer Research Center, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER